|
因应重点照护检验的各种技术融合 由于技术的进步，可以朝能迅速重点照护检验的诊断机器展开。最近为了诊断疾病，开发能在各种环境可靠分析之可搬式设备，加上改善患者管理，可提高便利性和使检验迅速化。此会议预定讨论最新的平台、试料制作和标识化、检查技术等最新动向。此外，亦报告POC诊断技术迅速普及的现状、因应技术持续增加医疗费的问题，以及变成将高品质的医疗提供给许多人之有效解决方案的状况。 第1天 | 第2天 10月11日星期二 9:00 Conference Registration and Morning Coffee
Opening Session 9:30 Chairperson’s Opening Remarks
10:05 Mobile Device for the Detection of MRSA and C. Difficile on Hospital Surfaces Andrew Gover, COO, Vantix, Ltd. Vantix Ltd. (formerly Universal Sensors) designs and manufactures Vantix™ biosensors that are sensitive, fast and versatile. It allows tests that traditionally take several hours of laboratory time to be performed in minutes and can be adapted for medical, veterinary and environmental applications. Through a Small Business Research Initiative (SBRI) competitive procurement process, Vantix is developing a portable device for the UK’s Department of Health to detect HCAI-related pathogens in hospital wards and care home settings. 10:35 Coffee Break - Networking with Sponsors 11:15 Industrialization & Economics of Smart Consumables in Life Sciences & Diagnostics Ali Tinazli, Ph.D., Senior Manager, Business Development, BioSciences, Sony DADC Austria AG Smart Consumables with microstructures / microfluidic features and functionalized surfaces are prerequisites for emerging applications in the Life Sciences and in-vitro Diagnostics (IVD) markets. The increasing complexity of such new products in those markets requires new manufacturing technologies. Sony DADC is now applying its excellence in customized mass manufacturing and its efficient processes to these highly sophisticated consumables in its new OEM business in a B2B format with leading, innovative companies in the biomedical field. 11:45 We Have the Technology: So Where Is the Roadmap to the Clinic? Vanya A. Gant, M.D., Ph.D., Director, Center for Infectious Diseases & International Health, University College London School of Medicine Diagnostic technologies now provide sublimely elegant solutions for detecting infectious agents. But technology alone can and will do nothing for better healthcare if not thoughtfully and appropriately integrated into clinical decision pathways. The speaker will illustrate these often poorly addressed if not completely overlooked issues of implementation with examples of failed technology for technology’s sake, and suggest some solutions. 12:15 Sponsored Presentations (Opportunities Available) 12:45 Lunch for Purchase and Poster Viewing in Exhibit Hall 9
DECENTRALIZED HEALTHCARE SYSTEMS 14:30 Chairperson’s Remarks
15:05 Creating a Regional Health Information Exchange System from Tertiary to Home Health Care Craig Lehmann, Ph.D., CC (NRCC), ASCP, FACB, Dean, School of Health Technology and Management; Professor, Clinical Laboratory Sciences, Stony Brook University This presentation will provide the details of building a regional health information exchange (HIE) system from an academic tertiary care medical center. The HIE consists of the following partners: hospitals, nursing homes, assisted living communities, physicians, diagnostics (laboratory and radiology) and presently incorporating software for home care. There will be a description of Point of Care Diagnostic Technologies that are available and utilized in today’s home along with the economic benefits of such a HIE system. 15:35 Refreshment Break - Networking with Sponsors
Spotlight on New Technologies 16:15 Sponsored Presentation (Opportunity Available) 16:45 Applying Nano Cantilever Technology to Detection of Organisms Vincent C. Emery, Ph.D., Infection, School of Life and Medical Sciences (Royal Free Campus), University College London Cantilever technology offers many opportunities for the direct detection of proteins such as antigens and antibodies against infectious organisms and potentially for the direct detection of organisms themselves. The latter is more challenging and I shall provide the latest update on our approaches to measure HIV particles using cantilever approaches based on developments made using novel antibodies and virus like particle systems optimized using SPR technology. 17:15 Diagnosing Tuberculosis within Two Hours: A Reality for TB POC Lesley Scott, Ph.D., Professor, Molecular Medicine and Hematology, University of Witwatersrand The TB and HIV epidemic in the developing world continues to pose enormous challenges to public health, including TB/HIV service integration. The Xpert MTB/RIF assay developed by Cepheid (Sunnyvale, CA) has recently been endorsed by the WHO as the initial method used to diagnose TB and replace smear microscopy. This molecular based POC assay has increased sensitivity, reduced turnaround time (2 hours) and immediate identification of rifampicin resistance, and therefore has potential to improve patient care and impact on global TB prevention. 17:45 Semiconductor Dx: From Sequencing to POC Chris Toumazou, Ph.D., CEO and Founder, DNA Electronics Ltd. DNA Electronics has developed a method for all-electronic detection of nucleic acid using standard semiconductor chips. This technology is key to recent developments in semiconductor sequencing by Ion Torrent and Roche 454 Life Sciences. However, the technology does not stop at sequencing. In this talk, we will also describe the semiconductor chips that do real-time amplification and detection of DNA. 18:15 Interactive Breakout Discussion Groups 19:15 BIOTECHNICA EVENT NIGHT – Keynote Presentation followed by Networking Reception. Live music and dancing. |
